Friday - July 17, 2026

IGC Pharma (NYSE: IGC) CEO and CFO Acquire More Than 4.2 Million Shares

IGC Pharma, Inc. (NYSE: IGC), a clinical-stage biotechnology company developing Alzheimer’s disease therapeutics and AI-enabled healthcare technologies, disclosed in a Form 4 filing that two senior executives increased their ownership stakes through debt-for-equity transactions. According to the filing dated July … Continue reading

Graphene Manufacturing (TSXV: GMG) (OTCQX: GMGMF) CEO Discusses Commercial Graphene Growth and Global Expansion Watch Now!

Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) continues to build momentum as the company expands production, secures new commercial partnerships, and advances the commercialization of its graphene technology platform. Founder and CEO Craig Nicol recently appeared on CEO.CA to … Continue reading